RecruitingNot ApplicableNCT06436326

The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes

The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes: Testing the Moderating Effects of Socioeconomic and Cultural Factors

Sponsor

National Taiwan University Hospital

Enrollment

120 participants

Start Date

Aug 22, 2024

Study Type

INTERVENTIONAL

Conditions

Continuous Glucose Monitoring Gestational Diabetes Mellitus

Summary

This study will discuss the impact of continuous glucose monitoring on maternal and infant's outcomes in gestational diabetes mellitus, and test the moderating effect of socioeconomic and cultural factors (dietary habits, socioeconomic status and income).

Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria3

Aged 18 years or above
Pregnant women diagnosed with gestational diabetes mellitus
Those who are willing to participate in this study

Exclusion Criteria3

Those who have been diagnosed with diabetes mellitus "before pregnancy"
Those whose skin is likely allergic to some materials such as tapes (signs and symptoms such as redness, swelling, itching, painful, presenting blisters or rashes caused by wearing breathable tapes, patches, etc.)
Those who is with abnormal coagulation function

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEContinuous glucose monitor

Participants will receive a set of continuous glucose monitor (CGM) at "24-32 weeks of pregnancy (first set)" and "33 weeks of pregnancy to before delivery (second set)," respectively. CGM wearing instruction will be provided before the first wearing at "24-32 weeks of pregnancy". After completing the first wearing (approximately 14 days after starting to wear), the investigators will provide a glucose monitor report. The second CGM was worn from the 33rd week of pregnancy to before delivery, and another glucose monitor report was given approximately 14 days after starting to wear.

BEHAVIORALPerinatal nursing care for gestational diabetes

Individual nursing care and consultation for pregnant women with gestational diabetes mellitus, including glucose monitor suggestions, dietary suggestions, emotional support, breastfeeding support.

OTHERBlood glucose meters (BGM)

Participants are required to use blood glucose meters (BGM) at "24-32 weeks of pregnancy" and "33 weeks to before delivery". After 14 days of glucose monitoring at "24-32 weeks of pregnancy", a glucose monitor report will be given to the participants. After the 14 days of glucose monitoring at "33 weeks to before delivery ", another glucose monitor report will be given to the participants.